Articles about Pfizer

Lead portfolio-level commercial strategy for Internal Medicine and Antivirals, prioritizing investments, advising senior leadership, and driving early commercial assessments, business development input, and AI-enabled decision frameworks to maximize portfolio value across development, launch, lifecycle, and external innovation.

Lead early commercial and portfolio strategy for Inflammation & Immunology pipeline assets. Develop long-range commercial plans, early product concepts, opportunity assessments, and decision materials. Partner cross-functionally with R&D, Medical Affairs, Access, Analytics, BD, and commercial teams. Use AI-enabled approaches to synthesize scientific, clinical, market, and competitive insights to inform portfolio priorities, investment decisions, and launch readiness.